Skip to content

Mental Health in the Aging Population

TL;DR

This study used the Geriatric Depression Scale and 7-day accelerometry to assess depression and PA in 30 older adults, and correlated these measures with participants’ RewP amplitude, showing that RewP amplitude did not statistically predict GDS scores among older adults.

Abstract

Though depression is a common and debilitating mental health disorder, little is known about its underlying neural mechanisms. In efforts to understand mechanisms, existing research has investigated anhedonia, a core symptom of depression, by focusing on neural correlates of reward processing, which is often assessed via the electroencephalography (EEG)-derived measure Reward Positivity (RewP). Importantly, most of these studies were done in younger populations, which is problematic as age-related cognitive changes may cause depression to manifest differently among older adults. Regarding treatment options, physical activity (PA) has been proposed as an antidepressant, but its benefits at the brain level remain poorly understood. Thus, in the present study, we used the Geriatric Depression Scale (GDS) and 7-day accelerometry to assess depression and PA, respectively, in 30 older adults, and correlated these measures with participants’ RewP amplitude. We predicted that a smaller RewP would be associated with greater GDS scores but that this relationship would be weaker for participants engaging in more lifestyle PA (i.e., unstructured activities of daily living). We focused specifically on lifestyle PA as it might be less daunting than structured exercise for those experiencing depressive symptoms (e.g., low motivation, fatigue). Results showed that RewP amplitude did not statistically predict GDS scores among older adults (p = .823). Further, no moderation effect of physical activity on RewP amplitude was observed (p = .601). Despite the null results, the design and innovative approaches (use of EEG and accelerometry in older adults) still render this study informative and highlight the need for more investigations targeting the mechanisms underlying depression in older adults.

View source

Similar papers

Review Open access Oct 2026

The Modern Face of Depression: A Comprehensive Review

Depression is one of most widespread disabling and one of most important global mental health problems among the main causes of disability, affecting more than 332 million people worldwide. The incidence has dramatically increased, especially among youths, who showed a clinically elevated symptom range, and who were in...

Nidhi Sharma · 0 citations
Review Open access Sep 2026

Brain health in older adults: At the crossroads of frailty and resilience

Brain health is a state of physiological functioning of the organ that allows individuals to fully achieve their age-related potential. Throughout life, a wide range of endogenous and exogenous factors can influence positively and negatively brain health. Among them, age is undoubtedly one of the most important, partic...

Mohammad Shahadat Hossain, Domenico Praticò · 0 citations
Open access Sep 2026

697. Psychiatric neuroscience: improving brain health, cognition and mental health

Abstract Background There is currently a global crisis in mental health. The World Health Organisation (WHO) has reported that over 1 billion people have a mental health disorder, with conditions such as anxiety and depression causing suffering to individuals and an economic burden to society1. In addition, the WHO rep...

B. Sahakian · 0 citations
Open access Sep 2026

EEG Functional Connectivity Reveals Accelerated Brain Aging in Young Adults with Cognitive Deficits and Mental Health Conditions

The discrepancy between chronological age and predicted brain age, derived from neuroimaging data, serves as a biomarker for neurological health. However, the exact electroencephalography (EEG) mechanisms contributing to the variation of brain age are yet to be understood. This paper comprehensively investigated the re...

C. Phang, Guo-Dong Miao, Lan-Tu Cai et al. · 0 citations
Review Open access Sep 2026

Age moderates the relationship between psychedelic use and mental health in naturalistic settings

Depression and anxiety affect one in five adults and vary across the lifespan; while prevalence generally declines with age until midlife, later life is marked by a re-emergence of symptoms. Although clinical trials suggest classic psychedelics (e.g., psilocybin, LSD) and non-classic psychedelics (e.g., MDMA, ketamin...

Giammarco Di Gregorio, Sophia Basset, Harjot Manmohan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.